Kelly E Jones

January 15, 2014 | New York Law Journal

Kelly E. Jones, a partner at Harris Beach, discusses innovator liability, which is premised on the notion that a brand-name pharmaceutical manufacturer that allegedly produced inadequate labeling on its brand-name drug has a legal duty to warn consumers, even those who ingested the competing generic version, and how this theory has fared in the courts.

By Kelly E. Jones

11 minute read

April 23, 2012 | New York Law Journal

Frederick H. Fern, a member of Harris Beach, and Kelly E. Jones, a senior associate at the firm, write that despite an overwhelming majority rule to the contrary, plaintiffs have already argued that 'Mensing' changes innovator liability analysis and requires that someone (i.e., the branded manufacturers) must be held accountable for injuries to a consumer injured by ingestion of a generic product with inadequate warnings.

By Frederick H. Fern and Kelly E. Jones

6 minute read